S100A8 and neoplasm: Under pathological conditions such as mechanical injury, infection, and immune disorders, bone marrow-derived cells—including neutrophils, monocytes, fibroblasts, tumor-associated phagocytes, and bone marrow-derived suppressor cells 14-17—synthesize and release substantial quantities of S100A8 and S100A9.